These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21211638)

  • 21. History of specific immunotherapy.
    Nelson HS
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2013; 97():3-5. PubMed ID: 24912305
    [No Abstract]   [Full Text] [Related]  

  • 22. Sublingual immunotherapy: from proven prevention to putative rapid relief of allergic symptoms.
    Bousquet J
    Allergy; 2005 Jan; 60(1):1-3. PubMed ID: 15575923
    [No Abstract]   [Full Text] [Related]  

  • 23. [MMW Drug Prize 2004 for Pollinex Quattro. Classic drug with a future].
    Krankenpfl J; 2004; 42(7-10):255-6. PubMed ID: 15675414
    [No Abstract]   [Full Text] [Related]  

  • 24. [Specific immunotherapy].
    Kapp A; Wedi B
    Hautarzt; 2006 Oct; 57(10):854. PubMed ID: 16955303
    [No Abstract]   [Full Text] [Related]  

  • 25. The history of sublingual immunotherapy.
    Pajno GB; Barberi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergen immunotherapy.
    Huggins JL; Looney RJ
    Am Fam Physician; 2004 Aug; 70(4):689-96. PubMed ID: 15338781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose sublingual immunotherapy: too much of the good?
    Reider N
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):125. PubMed ID: 16937740
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
    Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [100 years ago in the MMW: the birth of allergy. An overview from the beginnings to molecular therapy].
    Ring J
    MMW Fortschr Med; 2006 Jul; 148(29-30):23-4. PubMed ID: 16910401
    [No Abstract]   [Full Text] [Related]  

  • 30. [Status report on allergen immunotherapy (hyposensitisation). Prepared by the WHO/IUIS Immunotherapy Subcommittee 1988].
    Malling HJ
    Ugeskr Laeger; 1989 Nov; 151(48):3249-52. PubMed ID: 2595857
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk of home immunotherapy.
    Miller JD
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):290. PubMed ID: 17910336
    [No Abstract]   [Full Text] [Related]  

  • 32. [Allergy vaccination in Norway].
    Øymar K
    Tidsskr Nor Laegeforen; 2007 Apr; 127(8):1036-8. PubMed ID: 17457388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerated immunotherapy schedules: review of efficacy and safety.
    Cox L
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):126-37; quiz 137-40, 202. PubMed ID: 16937741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vaccination against allergy--why and how].
    Steinsvåg SK; Florvaag E
    Tidsskr Nor Laegeforen; 2005 Jun; 125(11):1489-90. PubMed ID: 15940315
    [No Abstract]   [Full Text] [Related]  

  • 35. EAACI guidelines on allergen immunotherapy: Executive statement.
    Muraro A; Roberts G; Halken S; Agache I; Angier E; Fernandez-Rivas M; Gerth van Wijk R; Jutel M; Lau S; Pajno G; Pfaar O; Ryan D; Sturm GJ; van Ree R; Varga EM; Bachert C; Calderon M; Canonica GW; Durham SR; Malling HJ; Wahn U; Sheikh A
    Allergy; 2018 Apr; 73(4):739-743. PubMed ID: 29380390
    [No Abstract]   [Full Text] [Related]  

  • 36. Disease-modifying effect and economic implications of sublingual immunotherapy.
    Canonica GW; Passalacqua G
    J Allergy Clin Immunol; 2011 Jan; 127(1):44-5. PubMed ID: 21094517
    [No Abstract]   [Full Text] [Related]  

  • 37. Sublingual immunotherapy: no more doubts.
    Passalacqua G; Lombardi C; Guerra L; Compalati E; Fumagalli F; Canonica GW
    Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):314-20. PubMed ID: 17066650
    [No Abstract]   [Full Text] [Related]  

  • 38. EAACI guidelines on allergen immunotherapy-Out with the old and in with the new.
    Agache I
    Allergy; 2018 Apr; 73(4):737-738. PubMed ID: 29319886
    [No Abstract]   [Full Text] [Related]  

  • 39. Allergy immunotherapy for primary care physicians.
    Stokes JR; Casale TB
    Am J Med; 2006 Oct; 119(10):820-3. PubMed ID: 17000208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health economics of allergen-specific immunotherapy in the United States.
    Lockey RF; Hankin CS
    J Allergy Clin Immunol; 2011 Jan; 127(1):39-43. PubMed ID: 21211640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.